1. Academic Validation
  2. Transcriptional regulation of adrenomedullin by oncostatin M in human astroglioma cells: implications for tumor invasion and migration

Transcriptional regulation of adrenomedullin by oncostatin M in human astroglioma cells: implications for tumor invasion and migration

  • Sci Rep. 2014 Sep 23;4:6444. doi: 10.1038/srep06444.
Seul Ye Lim 1 So-Hee Ahn 1 Hyunju Park 1 Jungsul Lee 2 Kyungsun Choi 2 Chulhee Choi 2 Ji Ha Choi 3 Eun-Mi Park 3 Youn-Hee Choi 1
Affiliations

Affiliations

  • 1 1] Department of Physiology, Global Top5 Research Program, School of Medicine, Ewha Womans University, Seoul, Korea [2] Tissue Injury Defense Research Center, School of Medicine, Ewha Womans University, Seoul, Korea.
  • 2 Department of Bio and Brain Engineering, KAIST, Daejeon, Korea.
  • 3 1] Tissue Injury Defense Research Center, School of Medicine, Ewha Womans University, Seoul, Korea [2] Department of Pharmacology, School of Medicine, Ewha Womans University, Seoul, Korea.
Abstract

Adrenomedullin (ADM), a secretory peptide with multiple functions in physiological to pathological conditions, is upregulated in several human cancers, including brain, breast, colon, prostate, and lung Cancer. However, the molecular mechanisms underlying the regulation of ADM expression in cancerous cells are not fully understood. Here, we report that oncostatin M (OSM), a cytokine belonging to the interleukin-6 family, induces ADM expression in astroglioma cells through induction of signal transducer and activator of transcription-3 (STAT-3) phosphorylation, nuclear translocation, and subsequent DNA binding to the ADM promoter. STAT-3 knockdown decreased OSM-mediated expression of ADM, indicating that ADM expression is regulated by STAT-3 in astroglioma cells. Lastly, scratch wound healing assay showed that astroglioma cell migration was significantly enhanced by ADM Peptides. These data suggest that aberrant activation of STAT-3, which is observed in malignant brain tumors, may function as one of the key regulators for ADM expression and glioma invasion.

Figures
Products